Press cutting from the financial pages of the Guardian, London:
Happy Bees
The dramatic rise (40 per cent in twelve weeks) in the value of ThreeBees Nairobi reflects growing market confidence in the company's recently acquired all-African franchise in the cheap and innovative cure for multi-resistant TB, Dypraxa. Speaking from his home in Monaco, ThreeBees CEO Kenneth K. Curtiss said: "What's good for ThreeBees is good for Africa. And what's good for Africa is good for Europe and America and the rest of the world."
Separate folder marked HIPPO in Tessa's hand containing some forty exchanges, first by letter, then by printed-out e-mail, between Tessa and a woman named Birgit, who works for an independently funded pharma-watch outfit called Hippo based in a small town called Bielefeld in north Germany. The logo at the top of her letter paper explains that her organization owes its name to Greek physician Hippocrates, born can. 460 B.C., whose oath all doctors swear. The correspondence begins formally but once the e-mails take over it softens. Key players quickly acquire nicknames. KVH becomes Giant, Dypraxa becomes Pill, Lorbeer becomes Goldmaker. Birgit's source on the activities of Karel Vita Hudson becomes "Our Friend" and Our Friend must be protected at all times, since "what she is telling us is completely against Swiss law."
E-mail printout Birgit to Tessa:
… for his two doctors Emrich and Kovacs, Goldmaker opened a company on Isle of Man, maybe two companies, because this was still Communist times. Our Friend says L put the companies in his own name so that the women wouldn't get bad trouble with the authorities. Since then there has been bad argument between the women. It is scientific, also personal. Nobody in Giant is allowed to know details. Emrich emigrated to Canada one year ago. Kovacs stays in Europe, mostly Basel. The elephant mobile you sent Carl drives him completely crazy with happiness and now he trumpets like an elephant every morning to tell me he is awake.
E-mail printout Birgit to Tessa: